Abstract: A medical device includes a shaft portion with a hollow shape and inflected portions or an exposed portion. The shaft portion is inserted into a cortical bone or penetrates through the cortical bone and is inserted to a position reaching a cancellous bone at an inner side of the cortical bone. The inflected portions are inflected to radial direction outer sides from one end portion of an axial direction of the shaft portion, and are exposed at a surface of the cortical bone. The exposed portion includes a portion that extends to the radial direction outer side from the one end portion of the axial direction of the shaft portion, and is exposed at the surface of the cortical bone.

Abstract: A denture base coating composition includes at least one selected from the group consisting of a first compound represented by Formula (1-0) and a second compound represented by Formula (2-0).

Abstract: A denture base coating composition includes at least one selected from the group consisting of a first compound represented by Formula (1-0) and a second compound represented by Formula (2-0).

Abstract: A medical device includes a shaft portion with a hollow shape and inflected portions or an exposed portion. The shaft portion is inserted into a cortical bone or penetrates through the cortical bone and is inserted to a position reaching a cancellous bone at an inner side of the cortical bone. The inflected portions are inflected to radial direction outer sides from one end portion of an axial direction of the shaft portion, and are exposed at a surface of the cortical bone. The exposed portion includes a portion that extends to the radial direction outer side from the one end portion of the axial direction of the shaft portion, and is exposed at the surface of the cortical bone.

Abstract: A biomaterial in which the surface of a metal base is coated with a coating agent containing a composite of hydroxyapatite and collagen in which the c-axis of hydroxyapatite in the composite is oriented along collagen fibers is used.

Abstract: This invention relates to a method for regulating the biodegradability of composite biomaterials comprising calcium salt (particularly hydroxyapatite) and collagen, improved composite biomaterials obtained via such method, and a method for increasing bone mass with the use of such composite biomaterials.

Abstract: This invention relates to a method for regulating the biodegradability of composite biomaterials comprising calcium salt (particularly hydroxyapatite) and collagen, improved composite biomaterials obtained via such method, and a method for increasing bone mass with the use of such composite biomaterials.

Abstract: The bone cement composition of the present invention comprises a liquid component including ethyl methacrylate as the main component and a powder component including an ethyl methacrylate/methyl methacrylate copolymer as the main component.

Abstract: The followings are disclosed herein: a biomaterial comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and &egr;-caprolactone; a biomaterial for the induction of osteoanagenesis, characterized in that a periosteum is attached to the biomaterial comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and &egr;-caprolactone; and a biomaterial for the prevention of adhesion comprising calcium phosphate and a copolymer of lactic acid, glycolic acid and &egr;-caprolactone where the molar ratio of lactic acid, glycolic acid and &egr;-caprolactone is within a range of 5-90:3-75:5-40.

Abstract: The present invention provides an absorbable barrier membrane for guided tissue regeneration which is useful for regeneration of animal tissues, including those of humans, the absorbable barrier membrane being superior in heat stability, processability, reproducibility, storage stability, bioabsorbablity, and tissue regeneration effects, and further provides a method for regeneration, using the absorbable barrier membrane, of a mandible, periodontal tissue, or defective tubulous bone, and particularly a defective tubulous bone which possesses a segmental bone defect in which both ends of the bone are in separate segments. The above objects are attained by an absorbable barrier membrane for use in guided tissue generation, comprising a lactic copolyester in which a polymerization catalyst is deactivated, as an essential component.